Hepatic Disease in HIV-Infected Patients

  • Author: Mark S. Sulkowski, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 9/4/18 (What's New)

Summary

  • HBV is identified by the presence of specific HBV antigens, HBV DNA, and anti-HBV antibodies (Table 3)
  • All persons with detectable HBsAg should undergo screening for hepatocellular carcinoma with liver ultrasounds performed at regular intervals (eg, every 6-12 months)
  • Most important clinical consideration is that persons potentially susceptible to HBV infection undergo vaccination

Action required

Keywords: Hepatic Complications, Special Populations, Viral Hepatitis Coinfection

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.